R&D Systems Recombinant Human CTRP2/C1qTNF2 CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9436TN050
DescriptionThe Recombinant Human CTRP2/C1qTNF2 Protein is derived from HEK293. The Recombinant Human CTRP2/C1qTNF2 Protein has been validated for the following applications: Bioactivity.
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|Human embryonic kidney cell, HEK293-derived|
|<0.10EU per 1μg of the protein by the LAL method.|
|Lyophilized from a 0.2μm filtered solution in HEPES and NaCl.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|C1q and tumor necrosis factor related protein 2, C1QTNF2, complement-c1q tumor necrosis factor-related protein 2, CTRP2complement C1q tumor necrosis factor-related protein 2, zacrp2|
|Reconstitute at 200μg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok